Neurofibroma, pleksiforminen的临床试验
总计283个结果
-
Children's National Research Institute主动,不招人
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)完全的未明确的儿童实体瘤,具体方案 | 恶性潜能未定的肿瘤美国
-
National Cancer Institute (NCI)终止
-
Shanghai Fosun Pharmaceutical Industrial Development...招聘中
-
AstraZenecaMerck Sharp & Dohme LLC主动,不招人神经纤维瘤病 1 | 丛状神经纤维瘤 (PN)美国, 加拿大, 法国, 意大利, 德国, 中国, 英国, 西班牙, 日本, 俄罗斯联邦, 澳大利亚, 波兰, 巴西
-
Spectrum Health HospitalsVan Andel Research Institute招聘中
-
Shanghai Ninth People's Hospital Affiliated to...招聘中
-
University of Alabama at BirminghamChildren's Hospital of Philadelphia; Congressionally Directed Medical Research Programs尚未招聘神经纤维瘤病 1 | 丛状神经纤维瘤
-
Novartis Pharmaceuticals终止
-
AstraZenecaMerck Sharp & Dohme LLC完全的
-
University of Alabama at BirminghamPacific Pediatric Neuro-Oncology Consortium; Array BioPharma主动,不招人
-
Assistance Publique - Hôpitaux de ParisNovartis完全的
-
SpringWorks Therapeutics, Inc.主动,不招人
-
National Cancer Institute (NCI)主动,不招人神经纤维瘤病 1 (NF1) | 丛状神经纤维瘤 (PN)美国
-
SpringWorks Therapeutics, Inc.可用的神经纤维瘤病 1 型相关丛状神经纤维瘤 | 组织细胞肿瘤 | 其他 MAP-K 通路驱动的疾病
-
AstraZeneca完全的
-
National Cancer Institute (NCI)招聘中
-
National Cancer Institute (NCI)完全的
-
Kent Robertson完全的
-
Children's Hospital of PhiladelphiaUnited States Department of Defense终止
-
National Cancer Institute (NCI)完全的
-
St. Justine's HospitalCHU de Quebec-Universite Laval; Montreal Children's Hospital of the MUHC主动,不招人
-
University of Alabama at Birmingham完全的
-
Indiana UniversityPfizer; United States Department of Defense终止
-
Indiana UniversityNovartis完全的
-
Shanghai Fosun Pharmaceutical Industrial Development...主动,不招人
-
Children's Hospital of Philadelphia终止
-
Novartis Pharmaceuticals完全的
-
Great Ormond Street Hospital for Children NHS Foundation...AstraZeneca完全的
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration Program招聘中
-
NFlection Therapeutics, Inc.完全的
-
Joergen SerupSahlgrenska University Hospital, Sweden主动,不招人
-
NFlection Therapeutics, Inc.完全的